MYNVAX

mynvax-logo

Mynvax is an Indian-based biotech startup that develops next-generation vaccines for influenza. In addition, the technology allows for very rapid, large-scale, and low-cost production of vaccines that could potentially be used to protect people when there is a pandemic. Mynvax, which was incubated at the Indian Institute of Science, was founded in 2017 by Raghavan Varadarajan and Gautham Nadig.

#SimilarOrganizations #People #Financial #Website #More

MYNVAX

Social Links:

Industry:
Biotechnology Health Care

Founded:
2017-05-05

Address:
Bangalore, Karnataka, India

Country:
India

Website Url:
http://www.mynvax.com

Total Employee:
1+

Status:
Active

Total Funding:
4.13 M USD


Similar Organizations

innovative-cellular-therapeutics-logo

Innovative Cellular Therapeutics

Innovative Cellular Therapeutics is a Shanghai-based biotechnology company engaged in research and development of cell therapy.

metis-therapeutics-logo

METiS Therapeutics

METiS Therapeutics uses integrated drug discovery to develop medicines in a variety of illness areas.

novellus-logo

Novellus

Novellus is a biotechnology company working to develop engineered cellular medicines.

paxvax-logo

PaxVax

PaxVax is a start-up developing candidate oral vaccines for key infectious diseases.

Current Employees Featured

not_available_image

Gautam Nadig
Gautam Nadig Founder @ Mynvax
Founder

not_available_image

Raghavan Varadarajan
Raghavan Varadarajan Founder @ Mynvax
Founder

Founder


not_available_image

Gautam Nadig

not_available_image

Raghavan Varadarajan

Investors List

accel_image

Accel

Accel investment in Series A - Mynvax

kotak-investment-advisors_image

Kotak Investment Advisors

Kotak Investment Advisors investment in Series A - Mynvax

1crowd_image

1Crowd

1Crowd investment in Series A - Mynvax

letsventure_image

LetsVenture

LetsVenture investment in Series A - Mynvax

ajith-sukumaran_image

Ajith Sukumaran

Ajith Sukumaran investment in Angel Round - Mynvax

Official Site Inspections

http://www.mynvax.com

  • Host name: 106.51.79.41.actcorp.in
  • IP address: 106.51.79.41
  • Location: Bengaluru India
  • Latitude: 12.9721
  • Longitude: 77.5933
  • Timezone: Asia/Kolkata
  • Postal: 560002

Loading ...

More informations about "Mynvax"

Mynvax

Mynvax, a clinical stage vaccine biotechnology company, was founded with the singular vision of developing novel, improved, recombinant, thermostable vaccines to protect against respiratory โ€ฆ See details»

Mynvax - Crunchbase Company Profile & Funding

Mynvax is an Indian-based biotech startup that develops next-generation vaccines for influenza. See details»

Mynvax Company Profile - Office Locations, Competitors, Revenue โ€ฆ

Mynvax has 5 employees at their 1 location and $4.2 m in total funding,. See insights on Mynvax including office locations, competitors, revenue, financials, executives, subsidiaries and more โ€ฆ See details»

Mynvax - A Funded Healthtech Startup Based Out Of Bengaluru

Mynvax is a company based in Bengaluru, Karnataka, India, operating in the healthtech sector. Founded in 2017, it now employs 27 individuals. The company was established by Gautam โ€ฆ See details»

Mynvax Company Profile Funding & Investors | YourStory

Efficacious vaccine for respiratory viruses.Mynvax is an Indian-based biotech startup that develops next-generation vaccines for influenza. In addition, the technology allows for very โ€ฆ See details»

MYNVAX PRIVATE LIMITED Company Profile - Dun & Bradstreet

Find company research, competitor information, contact details & financial data for MYNVAX PRIVATE LIMITED of Bengaluru, Karnataka. Get the latest business insights from Dun & โ€ฆ See details»

Mynvax: About Us

Mynvax has developed multiple collaborations in India and overseas, with leading researchers in vaccine design, formulation expertise and clinical development. As a biotech start-up โ€ฆ See details»

Mynvax - Accel

Mynvax led by Gautam Nadig and Raghavan Varadarajan has secured investment from Accel. Learn more. โ†’ See details»

Mynvax - Funding, Financials, Valuation & Investors - Crunchbase

Mynvax is an Indian-based biotech startup that develops next-generation vaccines for influenza. See details»

Current Opportunities - Mynvax

Mynvax Private Limited, a clinical stage vaccine biotechnology company is seeking applications for a Research Associate in process development to support its R&D and commercialization โ€ฆ See details»

Mynvax: Vaccine Design Workflow

Mynvax is currently working on two major vaccine programs: A multivalent vaccine against the human influenza virus. A broadly protective vaccine effective against SARS-CoV-2 and its โ€ฆ See details»

Mynvax: Career Opportunities

Mynvax is an equal-opportunity employer, and we celebrate the diversity of our teams across levels. We are committed to creating an environment where every person working with us โ€ฆ See details»

Mynvax: About Us

Gautham Nadig is co-founder and Executive Director of Mynvax Private Limited. Prior to co-founding Mynvax, Dr. Nadig was co-founder and Executive Director of Metahelix Life โ€ฆ See details»

Add a new organization to ROR: Mynvax Private Limited #2788

Summary of request: Add a new organization to ROR Name of organization: Mynvax Website: www.mynvax.com Link to publications: 10.1021/acs.jpcb.2c07262, 10.3390/v15020346 โ€ฆ See details»

Our investment in Mynvax - Accel

Mynvax, a biotech startup incubated at the Indian Institute of Science, Bangalore, has developed a recombinant vaccine platform that could revolutionize the domestic healthcare sector. The โ€ฆ See details»

Mynvax - Contacts, Employees, Board Members, Advisors

Mynvax is an Indian-based biotech startup that develops next-generation vaccines for influenza. See details»

mynvax | PDF | Vaccines | Biology

Mynvax Private Limited is offering a 2-year industrial post-doctoral research fellowship focused on developing recombinant vaccines for influenza and SARS-CoV-2, with a salary of Rs. 75,000 โ€ฆ See details»

Mynvax - 2025 Company Profile - Tracxn

Jun 14, 2025 Mynvax - Developer of novel recombinant vaccines to fight the human influenza virus and COVID19. Raised a total funding of $9.82M over 5 rounds from 76 investors. See details»

Mynvax Research Login

Mynvax Research Login Enter your email to get startedEmail See details»

National vaccine registry needed amid measles resurgence, โ€ฆ

1 hour ago As Dr. Theresa Tam retires from her role as Canadaโ€™s chief public health officer, she says thereโ€™s an urgent need for a national vaccine registry to help prevent and manage crises โ€ฆ See details»

linkstock.net © 2022. All rights reserved